Suppr超能文献

高危前列腺癌调强放疗和雄激素剥夺治疗后致死原因。

Causes of mortality after dose-escalated radiation therapy and androgen deprivation for high-risk prostate cancer.

机构信息

Department of Radiation Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio, USA.

出版信息

Int J Radiat Oncol Biol Phys. 2013 Sep 1;87(1):94-9. doi: 10.1016/j.ijrobp.2013.05.044.

Abstract

PURPOSE

Men with high-risk prostate cancer have other competing causes of mortality; however, current risk stratification schema do not account for comorbidities. We aim to identify the causes of death and factors predictive for mortality in this population.

METHODS AND MATERIALS

A total of 660 patients with high-risk prostate cancer were treated with definitive high-dose external beam radiation therapy (≥ 74 Gy) and androgen deprivation (AD) between 1996 and 2009 at a single institution. Cox proportional hazards regression analysis was conducted to determine factors predictive of survival.

RESULTS

The median radiation dose was 78 Gy, median duration of AD was 6 months, and median follow-up was 74 months. The 10-year overall survival (OS) was 60.6%. Prostate cancer was the leading single cause of death, with 10-year mortality of 14.1% (95% CI 10.7-17.6), compared with other cancers (8.4%, 95% CI 5.7-11.1), cardiovascular disease (7.3%, 95% CI 4.7-9.9), and all other causes (10.4%, 95% CI 7.2-13.6). On multivariate analysis, older age (HR 1.55, P=.002) and Charlson comorbidity index score (CS) ≥ 1 (HR 2.20, P<.0001) were significant factors predictive of OS, whereas Gleason score, T stage, prostate-specific antigen, duration of AD, radiation dose, smoking history, and body mass index were not. Men younger than 70 years of age with CS = 0 were more likely to die of prostate cancer than any other cause, whereas older men or those with CS ≥ 1 more commonly suffered non-prostate cancer death. The cumulative incidences of prostate cancer-specific mortality were similar regardless of age or comorbidities (P=.60).

CONCLUSIONS

Men with high-risk prostate cancer are more likely to die of causes other than prostate cancer, except for the subgroup of men younger than 70 years of age without comorbidities. Only older age and presence of comorbidities significantly predicted for OS, whereas prostate cancer- and treatment-related factors did not.

摘要

目的

患有高危前列腺癌的男性存在其他致死的竞争原因;然而,目前的风险分层方案并未考虑合并症。我们旨在确定该人群的死亡原因和预测死亡的因素。

方法与材料

1996 年至 2009 年,在一家机构接受根治性高剂量外照射治疗(≥74Gy)和雄激素剥夺(AD)治疗的 660 例高危前列腺癌患者纳入本研究。采用 Cox 比例风险回归分析确定生存预测因素。

结果

中位放射剂量为 78Gy,AD 中位持续时间为 6 个月,中位随访时间为 74 个月。10 年总生存率(OS)为 60.6%。前列腺癌是导致死亡的主要单一原因,10 年死亡率为 14.1%(95%CI 10.7-17.6),而其他癌症(8.4%,95%CI 5.7-11.1)、心血管疾病(7.3%,95%CI 4.7-9.9)和其他所有原因(10.4%,95%CI 7.2-13.6)。多因素分析显示,年龄较大(HR 1.55,P=0.002)和Charlson 合并症指数评分(CS)≥1(HR 2.20,P<0.0001)是 OS 的显著预测因素,而 Gleason 评分、T 分期、前列腺特异性抗原、AD 持续时间、放射剂量、吸烟史和体重指数则不是。年龄小于 70 岁且 CS=0 的男性死于前列腺癌的可能性大于其他任何原因,而年龄较大或 CS≥1 的男性更常见死于非前列腺癌。无论年龄或合并症如何,前列腺癌特异性死亡率的累积发生率相似(P=0.60)。

结论

患有高危前列腺癌的男性更有可能死于非前列腺癌原因,除了年龄小于 70 岁且无合并症的亚组男性。只有年龄较大和合并症的存在显著预测 OS,而前列腺癌和治疗相关因素则没有。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验